此前Astera Labs受Q2业绩大超预期(调整后EPS 0.80美元超预期0.69美元,营收3.924亿美元超预期3.607亿美元)及Q3指引远超市场预期(5.4亿至5.6亿美元 vs 预期4.17亿美元)驱动,叠加加皇银行上调目标价至500美元、摩根士丹利上调目标价至335美元,股价前期累积大幅涨幅。8月6日已出现逾7%的获利了结回落,8月10日再跌3.85%,当前下跌延续板块弱势下的前期涨幅兑现节奏。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.